Bioniq’s winning formula: Diogo Dalot joins Cristiano Ronaldo with over €1 million investment

London-based Bioniq, a company focused on personalised nutritional supplements based on blood biomarker data, announced today that football player Diogo Dalot, has joined the company as an investor, contributing over €1 million. Dalot, right-back for Manchester United and the Portugal national team, joins the global football star Cristiano Ronaldo, who became a major investor in 2024, […] The post Bioniq’s winning formula: Diogo Dalot joins Cristiano Ronaldo with over €1 million investment appeared first on EU-Startups.

Mar 18, 2025 - 12:41

Bioniq’s winning formula: Diogo Dalot joins Cristiano Ronaldo with over €1 million investment

London-based Bioniq, a company focused on personalised nutritional supplements based on blood biomarker data, announced today that football player Diogo Dalot, has joined the company as an investor, contributing over €1 million.

Dalot, right-back for Manchester United and the Portugal national team, joins the global football star Cristiano Ronaldo, who became a major investor in 2024, and brought Bioniq’s total valuation to €74.8 million.

“Diogo has an exceptional approach to performance optimisation and recovery, constantly seeking the most effective and scientifically backed methods to enhance his physical and cognitive capabilities,” said Vadim Fedotov, Founder and CEO of Bioniq. “His dedication to craft and commitment to maximising potential makes him a perfect fit for Bioniq. He shares our vision and mission, recognising that the future of health lies in precision, personalisation, and efficacy. His investment is yet another testament to this shift — where science-driven, individualised solutions create meaningful impact in the industry and everyday well-being.”

Founded in 2019 by Vadim Fedotov, a former player for the German national basketball team; and James Hardy, Bioniq offers AI-driven personalised supplements based on blood test data. After conducting years of testing, Bioniq has reportedly developed the largest of its kind proprietary biochemical database with blood test data from customers across 5 continents.

Shipping globally, Bioniq has created unique formulas for over 300k users that incorporate components and dosages tailor-made to each individual’s nutrient deficiencies, as identified through their blood results.

Dalot, a Bioniq member for over four years, has integrated the Bioniq formula into his daily routine to optimise health and performance. His involvement extends to active collaboration with the Bioniq team on product innovation, contributing his insights as a professional athlete.

With the launch of Bioniq’s hyper-personalised supplement, Build Your Own, Dalot has created an even more precise supplement routine, allowing him to vary his nutrient intake based on his performance goals. While the PRO formula is designed to reduce inflammation, increase resilience, and improve endurance, his adjunct Build Your Own allows mild inflammation as a natural part of the muscle-building process.

“When it comes to high-level performance, my biggest focus has always been finding that extra 1% — the key to setting myself apart from the rest. Since discovering Bioniq in 2022, it’s been a game-changer for me. I’ve seen the results for myself. Achieving such progress is only possible with a product that’s truly personalised and tailored specifically to my needs,” said Diogo Dalot. “Now, I’m thrilled to take the next step as an investor. I believe in Bioniq’s mission and see the tremendous potential of this business, especially with the growing global demand for personalised nutrition.”

Bioniq was developed to improve the physical and cognitive function of Olympic athletes. Today, products are available for customers from 70 countries, with its total user base growing more than 10x in 2024.

According to data provided by Bioniq, the supplements market was valued at €162 billion in 2023 and is projected to grow at a CAGR of 9.1% from 2024 to 2030.

Dalot’s investment follows the 2024 investment by Cristiano Ronaldo, as well as a successful Series B round, which raised €13.7 million, led by Principal Investors HV Capital and Unbound, two leading European VCs.

Bioniq’s quantifiable before-and-after snapshots of users’ nutrient needs and optimisation progress has been an asset in its partnerships with many leading health and sports institutions such as Lanserhof and UFC.

Bioniq has also been used by a range of athletes from the football World Cup Champions, NBA All-Stars, to Iron Man winners.

The post Bioniq’s winning formula: Diogo Dalot joins Cristiano Ronaldo with over €1 million investment appeared first on EU-Startups.